Le Lézard
Classified in: Health, Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

Astria Therapeutics to Report Third Quarter 2023 Financial Results and Provide a Corporate Update on Monday, November 13th


Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, will report third quarter 2023 financial results before the Nasdaq Global Market open on Monday, November 13, 2023. Jill C. Milne, Ph.D., Chief Executive Officer, will host a conference call and webcast at 8:30am ET to provide an update on corporate developments and to discuss third quarter financial results.

Webcast Information:

Interested parties may join the webcast via the Investors section of the Astria website, www.astriatx.com, or with the following link: https://lifescievents.com/event/astria-2/.

Please connect to the webcast several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be required. The webcast will be archived for 90 days.

About Astria Therapeutics:

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development for the treatment of hereditary angioedema. Our second program, STAR-0310, is a monoclonal antibody OX40 antagonist in preclinical development for the treatment of atopic dermatitis. Learn more about our company on our website, www.astriatx.com, or follow us on Twitter and Instagram @AstriaTx and on Facebook and LinkedIn.


These press releases may also interest you

at 20:07
Ascentage Pharma Received US$100 Million Option Payment from Takeda
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

at 20:05
SD Networks Set Framework for Asia Pacific Modernization
Enterprises in Asia Pacific are moving toward software-defined networking (SDN) to make communication more secure and resilient and speed up business decision-making, according to a new research report published today by Information Services Group...

at 20:00
Atara Biotherapeutics To Participate at the Stifel Virtual Cell Therapy Forum
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...

at 18:46
BOXABL Investors Have Now Indicated They Want to Invest Over $10MM in the Current Stock Offering! BOXABL Previously Sold Out the Reg A Crowdfund
BOXABL, the innovative housing startup known for its foldable Casita homes and building technology, has announced this week that investors have indicated they want to invest over $10MM in the current stock offering. BOXABL previously SOLD OUT the Reg...

at 18:40
Ryan Lawsuit Halts Federal Trade Commission (FTC) Ban on Non-Compete Agreements
Today, a federal court ruled for Ryan (a leading global tax services and software provider) and against the U.S. Federal Trade Commission (FTC), halting the FTC's ban on non-compete agreements set to take effect this fall. U.S. District Court Judge...

at 17:45
Automotive Battery Testers Market size is set to grow by USD 78.9 million from 2024-2028, Increasing lifespan of vehicles leading to growth in vehicle population to boost the market growth, Technavio
The global automotive battery testers market  size is estimated to grow by USD 78.9 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 3.73%  during the forecast period.  Increasing lifespan of...

More news about Science and technology...


News published on and distributed by: